Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1330)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$551.37
Total Value
$352.88K
Shares Held After
40,513
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
650
Price
$550.40
Total Value
$357.76K
Shares Held After
41,153
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
948
Price
$549.58
Total Value
$521.01K
Shares Held After
41,803
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,144
Price
$547.93
Total Value
$1.17M
Shares Held After
42,751
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,525
Price
$547.07
Total Value
$834.28K
Shares Held After
44,895
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,131
Price
$546.13
Total Value
$1.16M
Shares Held After
46,420
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,462
Price
$544.89
Total Value
$796.63K
Shares Held After
48,551
% of Holdings
2.9%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
524
Price
$2.11
Total Value
$1.11K
Shares Held After
514,903
% of Holdings
0.1%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
249
Price
$2.11
Total Value
$525.64
Shares Held After
506,748
% of Holdings
0.0%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
5,222
Price
$27.30
Total Value
$142.56K
Shares Held After
139,763
% of Holdings
3.6%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
60,547
Price
$0.40
Total Value
$24.22K
Shares Held After
377,211
% of Holdings
13.8%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
5,045
Price
$1.57
Total Value
$7.92K
Shares Held After
69,553
% of Holdings
7.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
49,966
Price
$1.57
Total Value
$78.45K
Shares Held After
688,926
% of Holdings
7.3%
Metagenomi Therapeutics, Inc. (MGX)
Wapnick Pamela — Chief Financial Officer
Shares
2,884
Price
$1.30
Total Value
$3.75K
Shares Held After
208,491
% of Holdings
1.4%
Metagenomi Therapeutics, Inc. (MGX)
Wein Matthew — General Counsel, Compliance Officer and Corporate Secretary
Shares
558
Price
$1.30
Total Value
$724.84
Shares Held After
126,491
% of Holdings
0.4%
Metagenomi Therapeutics, Inc. (MGX)
Irish Jian — Director
Shares
3,737
Price
$1.30
Total Value
$4.85K
Shares Held After
377,533
% of Holdings
1.0%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$19.27
Total Value
$19.27K
Shares Held After
43,415
% of Holdings
2.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
3,500
Price
$19.46
Total Value
$68.11K
Shares Held After
42,415
% of Holdings
8.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
6,000
Price
$19.48
Total Value
$116.88K
Shares Held After
38,915
% of Holdings
15.4%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
10,000
Price
$19.41
Total Value
$194.10K
Shares Held After
32,915
% of Holdings
23.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
500
Price
$19.44
Total Value
$9.72K
Shares Held After
42,915
% of Holdings
1.2%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
354
Price
$35.82
Total Value
$12.68K
Shares Held After
51,884
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
1,867
Price
$35.36
Total Value
$66.01K
Shares Held After
52,238
% of Holdings
3.5%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
7,779
Price
$34.28
Total Value
$266.66K
Shares Held After
54,105
% of Holdings
12.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
1,745
Price
$450.00
Total Value
$785.25K
Shares Held After
21,015
% of Holdings
7.7%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
3,500
Price
$2.05
Total Value
$7.17K
Shares Held After
11,279
% of Holdings
31.0%
Xenon Pharmaceuticals Inc. (XENE)
Cannon Gillian — Director
Shares
1,190
Price
$53.14
Total Value
$63.24K
Shares Held After
1,455
% of Holdings
45.0%
Xenon Pharmaceuticals Inc. (XENE)
PATOU GARY — Director
Shares
1,322
Price
$53.14
Total Value
$70.25K
Shares Held After
24,896
% of Holdings
5.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
4,415
Price
$68.96
Total Value
$304.46K
Shares Held After
4,318,447
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,437
Price
$67.88
Total Value
$572.74K
Shares Held After
4,322,862
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,148
Price
$67.20
Total Value
$480.34K
Shares Held After
4,331,299
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
4,416
Price
$68.96
Total Value
$304.52K
Shares Held After
515,686
% of Holdings
0.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,437
Price
$67.88
Total Value
$572.74K
Shares Held After
520,102
% of Holdings
1.6%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,147
Price
$67.20
Total Value
$480.27K
Shares Held After
528,539
% of Holdings
1.3%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
735,462
Price
$0.06
Total Value
$45.60K
Shares Held After
0
% of Holdings
100.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
24,946
Price
$0.40
Total Value
$9.98K
Shares Held After
437,758
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
98
Price
$550.53
Total Value
$53.95K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,202
Price
$549.77
Total Value
$660.83K
Shares Held After
40,611
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,289
Price
$548.81
Total Value
$707.42K
Shares Held After
41,813
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,366
Price
$547.85
Total Value
$1.30M
Shares Held After
43,102
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,808
Price
$546.88
Total Value
$1.54M
Shares Held After
45,468
% of Holdings
5.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,737
Price
$545.99
Total Value
$948.38K
Shares Held After
48,276
% of Holdings
3.5%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
2,064
Price
$64.14
Total Value
$132.38K
Shares Held After
1,785,242
% of Holdings
0.1%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
15,401
Price
$6.40
Total Value
$98.57K
Shares Held After
700,000
% of Holdings
2.2%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
1,858
Price
$103.78
Total Value
$192.82K
Shares Held After
60,486
% of Holdings
3.0%
Equillium, Inc. (EQ)
Connelly Stephen — President and CSO
Shares
30,975
Price
$2.94
Total Value
$91.07K
Shares Held After
762,025
% of Holdings
3.9%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
14,584
Price
$2.93
Total Value
$42.74K
Shares Held After
62,586
% of Holdings
18.9%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Khan Najat — Director
Shares
23,588
Price
$3.58
Total Value
$84.46K
Shares Held After
2,175,796
% of Holdings
1.1%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.62
Total Value
$144.80K
Shares Held After
883,735
% of Holdings
4.3%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,064
Price
$4.42
Total Value
$9.12K
Shares Held After
173,224
% of Holdings
1.2%
Showing 151–200 of 1330 transactions (page 4 of 27)